Sort   by:  
 Page size 
ProteomicsTargeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCC
The NFE2L2/NRF2 oncogene and transcription factor drives a gene expression program that promotes cancer progression, metabolic reprogramming, immune evasion and chemoradiation resistance. Patient stratification by NRF2 activity may guide treatment decisions to improve outcome. Here, we developed a m...
ORGANISM(S): Homo sapiens (Human) 
2023-06-08 | PXD041163 | Pride
Hpv Oropharynx tumor Oral cavity tumor Hnscc Nrf2 
ProteomicsTargeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCC
The NFE2L2/NRF2 oncogene and transcription factor drives a gene expression program that promotes cancer progression, metabolic reprogramming, immune evasion and chemoradiation resistance. Patient stratification by NRF2 activity may guide treatment decisions to improve outcome. Here, we developed a m...
ORGANISM(S): Homo sapiens (Human) 
2023-06-08 | PXD041162 | Pride
Hnscc Nrf2 Luad Lusc 
ProteomicsTargeted proteomics quantittation of NRF2 signaling and predictive biomarkers in HNSCC
The NFE2L2/NRF2 oncogene and transcription factor drives a gene expression program that promotes cancer progression, metabolic reprogramming, immune evasion and chemoradiation resistance. Patient stratification by NRF2 activity may guide treatment decisions to improve outcome. Here, we developed a m...
ORGANISM(S): Homo sapiens (Human) 
2023-06-13 | PXD042949 | Pride
Lc-ms/ms 
Sort   by:  
 Page size